Thrombocytopenia before and after transcatheter aortic valve replacement (TAVR) is frequently observed, but its clinical impact on later outcomes remains unclear. We retrospectively reviewed a total of 444 consecutive patients… Click to show full abstract
Thrombocytopenia before and after transcatheter aortic valve replacement (TAVR) is frequently observed, but its clinical impact on later outcomes remains unclear. We retrospectively reviewed a total of 444 consecutive patients who underwent TAVR (transfemoral, n = 370; nontransfemoral, n = 74) at
               
Click one of the above tabs to view related content.